Unichem Laboratories Limited — Board Meeting, 28-03-2025: Outcome of Board Meeting

The Board of Directors has approved the transfer of its entire stake in Unichem Laboratories Limited, Ireland to its parent company, Ipca Laboratories Limited, with an expected completion date on or before 30th April 2025. Additionally, the Board proposed the closure of Niche Generics Limited’s manufacturing facility in Ireland due to ongoing losses, with the closure targeted for Q1 FY 2025-26. The facility’s high operational costs and lease expiration contributed to this decision. Overall, these strategic moves aim to enhance operational efficiency without adversely impacting business continuity. The consideration for the stake sale is ₹4.00 crore.